.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
US Army
Citi
Federal Trade Commission
Chubb
Julphar
Mallinckrodt
Cipla
Johnson and Johnson
Teva

Generated: July 26, 2017

DrugPatentWatch Database Preview

ULTRA-TECHNEKOW FM Drug Profile

« Back to Dashboard

Which patents cover Ultra-technekow Fm, and when can generic versions of Ultra-technekow Fm launch?

Ultra-technekow Fm is a drug marketed by Mallinkrodt Nuclear and is included in one NDA.

The generic ingredient in ULTRA-TECHNEKOW FM is technetium tc-99m sodium pertechnetate generator. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m sodium pertechnetate generator profile page.

Summary for Tradename: ULTRA-TECHNEKOW FM

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list232
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ULTRA-TECHNEKOW FM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinkrodt Nuclear
ULTRA-TECHNEKOW FM
technetium tc-99m sodium pertechnetate generator
SOLUTION;INTRAVENOUS017243-003Feb 18, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Mallinkrodt Nuclear
ULTRA-TECHNEKOW FM
technetium tc-99m sodium pertechnetate generator
SOLUTION;INTRAVENOUS017243-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
McKinsey
Novartis
Moodys
Fish and Richardson
Mallinckrodt
Colorcon
Express Scripts
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot